Institutional investors purchased a net $1.6 million shares of IPXL during the quarter ended September 2014, and now own 84.69% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SLATE PATH CAPITAL LP Bought 2.3 Million shares of Impax Laboratories Inc